Schedule 13G ownership disclosure
Indivior Pharmaceuticals Inc
Security class unavailable · CUSIP: 04546C106
Event date: 2020-05-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,947,025
- Percent of class
- 6.2600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-20-002250
- Form type
- SC 13G
- Filer
- Assertio Holdings, Inc.
- CIK
- CIK 1808665
- Filed
- Jun 01, 2020
- Reporting period
- May 20, 2020
- Description
- Schedule 13G beneficial ownership